Tasigna and Cleocin t drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Tasigna and Cleocin t together.
The phase IV clinical study analyzes what interactions people who take Tasigna and Cleocin t have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Tasigna and Cleocin t together, and have interactions are studied.
What is Tasigna?
Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 28,631 Tasigna users for its effectiveness, alternative drugs and more.
What is Cleocin t?
Cleocin t has active ingredients of clindamycin phosphate. eHealthMe is studying from 544 Cleocin t users for its effectiveness, alternative drugs and more.
Number of Tasigna and Cleocin t reports submitted per year:
Common Tasigna and Cleocin T drug interactions by gender *:
female:
n/a
male:
- Rash erythematous
- Chest pain
Common Tasigna and Cleocin T drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Rash erythematous
- Chest pain
* Approximation only. Some reports may have incomplete information.
Do you take Tasigna and Cleocin t?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Tasigna and Cleocin t:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Tasigna side effects:
- Death: 3,018 reports
- Fatigue (feeling of tiredness): 2,362 reports
- Rashes (redness): 2,305 reports
- Headache (pain in head): 1,622 reports
- Thrombocytopenia (decrease of platelets in blood): 1,553 reports
- Pain: 1,524 reports
- Breathing difficulty: 1,491 reports
Browse all side effects of Tasigna:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Tasigna interactions:
- Tasigna and Aspirin: 1,067 reports
- Tasigna and Gleevec: 884 reports
- Tasigna and Sprycel: 851 reports
- Tasigna and Lopurin: 800 reports
- Tasigna and Glivec: 652 reports
- Tasigna and Metformin: 586 reports
- Tasigna and Lasix: 584 reports
- Tasigna and Omeprazole: 546 reports
- Tasigna and Amlodipine: 527 reports
- Tasigna and Furosemide: 486 reports
Browse all interactions between Tasigna and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cleocin t interactions:
- Cleocin t and Accutane: 161 reports
Browse all interactions between Cleocin t and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nilotinib hydrochloride monohydrate and clindamycin phosphate (the active ingredients of Tasigna and Cleocin t, respectively), and Tasigna and Cleocin t (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tasigna and Cleocin t.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lupron and Fluid Retention - 13 seconds ago
- Valsartan and Weakness - 18 seconds ago
- Prilosec and Confusion Aggravated - 20 seconds ago
- Polaramine and Nasal Congestion - 20 seconds ago
- Raynaud'S Phenomenon and Iron Deficiency Anaemia - 24 seconds ago
- Amlodipine and Diastat drug interaction - 24 seconds ago
- Azithromycin and Prostatitis - 28 seconds ago
- Taxotere and Rheumatoid Arthritis - 33 seconds ago
- Acetylsalicylic Acid and Synthroid drug interaction - 38 seconds ago
- Clopra and Venous Pressure Increased - 38 seconds ago